Cafedrine
Chemical linkage of norephedrine and theophylline
- C01CA21 (WHO)
- (RS)-7-[2-[(1-hydroxy-1-phenylpropan-2-yl)amino]ethyl]-1,3-dimethylpurine-2,6-dione
- 58166-83-9
Y
- 5489638
- 4590188 Y
- 0UYY5V4U2Q
- ChEMBL2104207
N
- DTXSID50866678
- Interactive image
- O=C2N(c1ncn(c1C(=O)N2C)CCNC(C)C(O)c3ccccc3)C
InChI
- InChI=1S/C18H23N5O3/c1-12(15(24)13-7-5-4-6-8-13)19-9-10-23-11-20-16-14(23)17(25)22(3)18(26)21(16)2/h4-8,11-12,15,19,24H,9-10H2,1-3H3/t12-,15-/m0/s1Y
- Key:UJSKUDDDPKGBJY-WFASDCNBSA-NY
N
Y (what is this?) (verify)Cafedrine (INN), also known as norephedrinoethyltheophylline, is a chemical linkage of norephedrine and theophylline and is a cardiac stimulant used to increase blood pressure in people with hypotension.[1]
See also
- Fenethylline
- Theodrenaline
References
- ^ Morton IK, Hall JM (1999). "Calcitonin gene-related peptide receptor antagonist". Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Dordrecht: Springer Netherlands. p. 59. ISBN 9789401144391.
- v
- t
- e
Cardiac stimulants excluding cardiac glycosides (C01C)
dopaminergic agents
| Adrenergic agonists |
| ||||||
|---|---|---|---|---|---|---|---|
| Dopamine agonists | |||||||
| Both | |||||||
| Unknown/ungrouped |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
